2 results match your criteria: "Brive Hospital Center[Affiliation]"
Results of the RE-DINO multicenter randomized trial on the repeated use of vaginal dinoprostone (Propess®) for labor induction in patients at term.
Am J Obstet Gynecol MFM
November 2024
Department of Gynecology and Obstetrics, Brive Hospital Center, Brive, France (Siegerth, Cantaloube, and Hessas).
Article Synopsis
- - Labor induction in France often involves using intravaginal dinoprostone (Propess®), but there's debate on whether to repeat this or switch to oxytocin if labor doesn’t start within 24 hours.
- - The study aimed to compare the effectiveness of a second Propess® placement followed by oxytocin versus direct oxytocin in increasing vaginal delivery rates among pregnant women who didn’t respond to the first Propess®.
- - Results showed no significant difference in vaginal delivery rates between the two methods (76.3% for the second Propess® vs. 73.8% for oxytocin), but more cesarean sections occurred in the Propess® group due to dilation issues.
Coronary Artery Embolism Following Aortic Valve Replacement.
J Card Surg
July 2015
Department of Thoracic and Cardiovascular Surgery and Angiology, Dupuytren University Hospital Center, Limoges, France.